Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

Conditions:   Clinical Stage IV Esophageal Adenocarcinoma AJCC v8;   Clinical Stage IV Gastric Cancer AJCC v8;   Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8;   Clinical Stage IVA Gastric Cancer AJCC v8;   Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8;   Clinical Stage IVB G astric Cancer AJCC v8;   Metastatic Esophageal Adenocarcinoma;   Metastatic Gastric Adenocarcinoma;   Oligometastatic Esophageal Adenocarcinoma;   Oligometastatic Gastric Adenocarcinoma;   Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IV Gastric Cance r AJCC v8;   Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8 Interventions:   Drug: Capecitabine;   Drug: Fluorouracil;   Drug: Leucovorin;   Drug: Leucovorin Calcium;   Drug: Oxaliplatin;   Radiation: Radiation Therapy Sponsors:   ECOG-ACRIN Cancer Research Group;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials